{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ADMA Biologics Inc"},"Symbol":{"label":"Symbol","value":"ADMA"},"Address":{"label":"Address","value":"465 STATE ROUTE 17, RAMSEY, New Jersey, 07446, United States"},"Phone":{"label":"Phone","value":"+1 201 478-5552"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services."},"CompanyUrl":{"label":"Company Url","value":"https://www.admabiologics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adam S. Grossman","title":"President, Chief Executive Officer & Director"},{"name":"Kaitlin Kestenberg","title":"Chief Operating Officer & Senior VP-Compliance"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}